Rivaroxaban, a direct inhibitor of coagulation factor Xa, attenuates adverse cardiac remodeling in rats by regulating the PAR-2 and TGF-β1 signaling pathways
Article in PeerJ (September 2023)
The most recent citing publications are shown below. View all 74 publications that cite this research output on Dimensions.
Article in PeerJ (September 2023)
Preprint in medRxiv (September 2023)
Article in Small (July 2023)